Hepatorenal syndrome treatment with terlipressin and albumin

被引：0
作者：
Hamilton M. [1 ]
机构：
[1] University College London Hospital, London
来源：
Critical Care | / 2卷 / 1期
关键词：
Albumin; Cirrhosis; Critical care; Hepatorenal syndrome; Terlipressin; Vasopressin agonists;
D O I：
10.1186/ccf-2000-6039
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
相关论文
共 50 条
  • [31] Hepatorenal syndrome - Long-term treatment with terlipressin as a bridge to liver transplantation
    GanneCarrie, N
    Hadengue, A
    Mathurin, P
    Durand, F
    Erlinger, S
    Benhamou, JP
    DIGESTIVE DISEASES AND SCIENCES, 1996, 41 (06) : 1054 - 1056
  • [32] Terlipressin for Type 1 Hepatorenal Syndrome
    Terbah, R.
    Gow, P.
    Sinclair, M.
    Testro, A.
    DIGESTIVE DISEASES AND SCIENCES, 2020, 65 (08) : 2454 - 2455
  • [33] Continuous recurrence of type 1 hepatorenal syndrome and long-term treatment with terlipressin and albumin: A new exception to MELD score in the allocation system to liver transplantation?
    Piano, Salvatore
    Morando, Filippo
    Fasolato, Silvano
    Cavallin, Marta
    Boscato, Novella
    Boccagni, Patrizia
    Zanus, Giacomo
    Cillo, Umberto
    Gatta, Angelo
    Angeli, Paolo
    JOURNAL OF HEPATOLOGY, 2011, 55 (02) : 491 - 496
  • [34] Terlipressin in combination with albumin as a therapy for hepatorenal syndrome in patients aged 65 years or older
    Mujtaba, Muhammad A.
    Gamilla-Crudo, Ann Kathleen
    Merwat, Shehzad N.
    Hussain, Syed A.
    Kueht, Michael
    Karim, Aftab
    Khattak, Muhammad W.
    Rooney, Peggy J.
    Jamil, Khurram
    ANNALS OF HEPATOLOGY, 2023, 28 (05)
  • [35] Terlipressin versus noradrenaline in the treatment of hepatorenal syndrome: systematic review with meta-analysis and full economic evaluation
    de Mattos, Angelo Z.
    de Mattos, Angelo A.
    Ribeiro, Rodrigo A.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 28 (03) : 345 - 351
  • [36] A Systematic Review of the Emerging Treatment for Hepatorenal Syndrome With a Principal Focus on Terlipressin: A Recent FDA-Approved Drug
    Thangaraj, Santhosh Raja
    Srinivasan, Mirra
    Arzoun, Hadia
    Thomas, Siji S.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)
  • [37] Terlipressin plus hydroxyethyl starch infusion:: an effective treatment for hepatorenal syndrome
    Saner, FH
    Frühauf, NR
    Schäfers, RF
    Lang, HK
    Malagó, M
    Broelsch, CE
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2003, 15 (08) : 925 - 927
  • [38] Randomized Controlled Trial Comparing the Efficacy of Terlipressin and Albumin with a Combination of Concurrent Dopamine, Furosemide, and Albumin in Hepatorenal Syndrome
    Srivastava, Siddharth
    Shalimar
    Vishnubhatla, Sreenivas
    Prakash, Shyam
    Sharma, Hanish
    Thakur, Bhaskar
    Acharya, Subrat K.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2015, 5 (04) : 276 - 285
  • [39] Terlipressin and gelafundin:: Safe therapy of hepatorenal syndrome
    Saner, FH
    Kavuk, I
    Lang, H
    Biglarnia, R
    Frühauf, NR
    Schäfers, RF
    Malagó, M
    Broelsch, CE
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2004, 9 (02) : 78 - 82
  • [40] Terlipressin versus placebo or noradrenalin in the treatment of hepatorenal syndrome: a systematic review and meta-analysis
    Wan, Yue-Meng
    Huang, Song-Quan
    Wu, Hua-Mei
    Li, Yu-Hua
    Yin, Hong-Jing
    Xu, Ying
    FRONTIERS IN PHARMACOLOGY, 2024, 15
12345